Hyderabad-based Suven Life Sciences (Suven) has started recruiting patients for the Phase 3 trial of this novel drug that could possibly slow cognitive decline.
The company's stock surged nearly 9 per cent during the day's trade on the BSE.
Alzheimer's is a progressive neurological, degenerative disorder that causes the brain to shrink and the brain cells to die. According to a 2021 Lancet study on the burden of neurological disorders in India's states, Alzheimer's has claimed 129,000 lives in the country in 2019. About 3.7 per cent, or 6.1 million, senior citizens suffer from dementia.
This number is expected to treble by 2050, warns Jasrita Dhir, head-marketing and communications, Antara Senior Living.
Suven said on Wednesday it has started randomisation of the first patient in the Phase 3 global clinical trial of its drug Masupirdine for the treatment of agitation in patients with dementia of the Alzheimer's type. Clinical trial randomisation is the process of assigning patients by chance to groups that receive different treatments.
It is a multi-centre, randomised, double-blind, placebo-controlled study planned across 50 cities in North America and Europe.
"The study will enrol approximately 375 patients who will be randomised in a 1:1:1 to receive.
Esta historia es de la edición November 18, 2022 de Business Standard.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 8500 revistas y periódicos.
Ya eres suscriptor ? Conectar
Esta historia es de la edición November 18, 2022 de Business Standard.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 8500 revistas y periódicos.
Ya eres suscriptor? Conectar
Bandhan Bank Q4 profit falls 94% to ₹54.6 crore
Bandhan Bank on Friday reported a 93.24 per cent drop in its net profit to ₹54.6 crore in the March quarter (Q4FY24) compared to a profit of ₹808.3 crore in the corresponding quarter of the previous financial year.
UN ups India's CY24 growth forecast
The United Nations (UN) has revised upwards India's growth forecast for 2024 by 70 basis points to 6.9 per cent, from 6.2 per cent estimated in January this year, driven by robust public investment and resilient private consumption.
RBI flags concerns over functioning of debt recast firms
Meeting with ARCS part of supervisory engagements
Adani Ports & SEZ shares stable after Norges Bank exit
A day after Norway's Norges Bank decided to sell its shares in Adani Ports & Special Economic Zone, the company's shares closed stable at ₹1,336 a share on Friday.
Trent, Bharat Electronics in Nifty 50 contention
Tata group retailer Trent and state-owned Bharat Electronics Ltd (BEL) are seen as likely contenders to the benchmark Nifty 50 index during the next rebalancing exercise in September.
M&M stock races ahead on strong Q4 results, healthy outlook
Mahindra (M&M) reported very strong results for the January-March quarter of the last financial year (Q4FY24), beating consensus comfortably.
Silver outpaces gold as buying gains momentum
Gold's record-setting rally may have captured the headlines this year, but it's silver that's running harder and faster as the less glamorous metal benefits from robust financial and industrial demand.
Go Digit IPO booked 9.6x on last day, QIBS bet big
The ₹2,615 crore initial public offering (IPO) of the Fairfaxbacked Go Digit General Insurance closed on Friday, with the issue getting subscribed over 9.6 times.
Bajaj MF adds to variety in multi-asset space
Takes the dividend yield route to stand out in emerging hybrid category
Heavyweights lift Sensex, Nifty
Equity benchmarks Sensex and Nifty closed higher for a second straight day on Friday as buying in index majors M&M, Reliance Industries, and ITC helped the indices rebound from early lows.
